EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-Field Benchtop NMR to Discover Early-Onset Sepsis: A Proof of Concept

Matteo Stocchero iD, Claire Cannet, Claudia Napoli, Elena Demetrio, Eugenio Baraldi, Giuseppe Giordano

Metabolites · 21.09.2023 · 13 (9) · 1029

DOI: 10.3390/metabo13091029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 21.09.2023. Verfasst von Matteo Stocchero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Women's and Children's Health Department, University of Padova, 35128 Padova, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-field (LF) benchtop NMR is a new family of instruments available on the market, promising for fast metabolic fingerprinting and targeted quantification of specific metabolites despite a lack of sensitivity and resolution with respect to high-field (HF) instruments. In the present study, we evaluated the possibility to use the urinary metabolic fingerprint generated using a benchtop LF NMR instrument for an early detection of sepsis in preterm newborns, considering a cohort of neonates previously investigated by untargeted metabolomics based on Mass Spectrometry (MS). The classifier obtained behaved similarly to that based on MS, even if different classes of metabolites were taken into account. Indeed, investigating the regions of interest mainly related to the development of sepsis by a HF NMR instrument, we discovered a set of relevant metabolites associated to sepsis. The set included metabolites that were not detected by MS, but that were reported as relevant in other published studies. Moreover, a strong correlation between LF and HF NMR spectra was observed. The high reproducibility of the NMR spectra, the interpretability of the fingerprint in terms of metabolites and the ease of use make LF benchtop NMR instruments promising in discovering early-onset sepsis.

Schlagwörter

Stichwörter der Autor:innen

fingerprintinglow-field benchtop NMRmetabolomicssepsis

Autor:innen und Institutionen

  • Women's and Children's Health Department, University of Padova, 35128 Padova, Italy.
  • Fondazione Istituto di Ricerca Pediatrica Città della Speranza, 35127 Padova, Italy.
  • Bruker BioSpin GmbH, 76275 Ettlingen, Germany.
  • Bruker Italia S.r.l., 20158 Milano, Italy.

ORCID-Profile: Matteo Stocchero

Zitieren

APA

Stocchero, M., Cannet, C., Napoli, C., Demetrio, E., Baraldi, E., & Giordano, G. (2023). Low-Field Benchtop NMR to Discover Early-Onset Sepsis: A Proof of Concept. Metabolites, 13(9), 1029. https://doi.org/10.3390/metabo13091029

Vancouver

Stocchero M, Cannet C, Napoli C, Demetrio E, Baraldi E, Giordano G. Low-Field Benchtop NMR to Discover Early-Onset Sepsis: A Proof of Concept. Metabolites. 2023;13(9):1029. doi:10.3390/metabo13091029

BibTeX
@article{Stocchero2023,
  author = {Stocchero, Matteo and Cannet, Claire and Napoli, Claudia and Demetrio, Elena and Baraldi, Eugenio and Giordano, Giuseppe},
  title = {Low-Field Benchtop NMR to Discover Early-Onset Sepsis: A Proof of Concept},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {1029},
  doi = {10.3390/metabo13091029}
}
Kostenlos starten →